Saltikva

N/A

Report date: 2025/01/08 10:37:38

Base Information

Drug NameSaltikva

Drug Alias Namesalmonella-IL2Attenuated Salmonella typhimurium containing human IL-2SALTIKVAMDB401B

ClassificationCell and gene therapy > Gene therapy > Bacterial vector-based gene therapy > Attenuated Salmonella Typhimurium vectorBiologics > Oncolytic bacteria

Mechanisms of ActionInterleukin-2 replacements

TargetsInterleukin-2

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesSalspera LLC Sunshine Lake Pharma

China Registration ClassN/A

Develop Information

Active CompaniesSalspera LLC

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A